Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
SYBX - Synlogic, Inc.
Market Cap 35.28M P/E - EPS this Y 69.20% Ern Qtrly Grth -
Income -56.16M Forward P/E -0.53 EPS next Y 82.70% 50D Avg Chg -
Sales 3.17M PEG - EPS past 5Y - 200D Avg Chg -24.00%
Dividend N/A Price/Book 0.51 EPS next 5Y - 52W High Chg -62.00%
Recommedations 3.00 Quick Ratio 3.53 Shares Outstanding 11.70M 52W Low Chg 32.00%
Insider Own 15.58% ROA -46.07% Shares Float 3.61M Beta 0.84
Inst Own 60.85% ROE -158.75% Shares Shorted/Prior 55.96K/48.18K Price 0.52
Gross Margin 100.00% Profit Margin - Avg. Volume 397,087 Target Price -
Oper. Margin -1,173.38% Earnings Date Nov 7 Volume 60,686 Change -0.50%
Healthcare | Biotechnology | United States
About Synlogic, Inc.

Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotics to treat metabolic diseases in the United States. Its pipeline include SYNB1618, an orally administered, non-systemically absorbed drug candidate to treat phenylketonuria; SYNB1934, an orally administered, non-systemically absorbed drug candidate, which is in Phase III clinical trial to treat phenylketonuria; SYNB1353, an orally administered, non-systemically absorbed drug candidate, which is in Phase I clinical to treat homocystinuria; SYNB8802, an orally administered, non-systemically absorbed drug candidate that is in Phase II clinical trial for the treatment of enteric hyperoxaluria; and SYNB2081 to lower uric acid for the potential treatment of gout. The company has a collaboration agreement with F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc. for the research and pre-clinical development of a synthetic biotic medicine for the treatment of inflammatory bowel disease; and Ginkgo Bioworks, Inc. Synlogic, Inc. is based in Cambridge, Massachusetts.

Synlogic, Inc. News
11/15/24 Synlogic Third Quarter 2024 Earnings: US$0.01 loss per share (vs US$2.57 loss in 3Q 2023)
11/12/24 Synlogic Reports Third Quarter 2024 Financial Results
08/09/24 Otsuka snaps up Jnana with its phenylketonuria drug for $800m
08/08/24 Synlogic Reports Second Quarter 2024 Financial Results
05/23/24 The Summer Stock Exodus: 3 Companies to Ditch Before the Heat Hits
05/14/24 Synlogic Reports First Quarter 2024 Financial Results
05/09/24 We Think Synlogic (NASDAQ:SYBX) Needs To Drive Business Growth Carefully
03/19/24 Synlogic, Inc. (SYBX) Reports Q4 Loss, Tops Revenue Estimates
03/19/24 Synlogic Reports Fourth Quarter and Full Year 2023 Financial Results
02/20/24 Synlogic Adopts Limited Duration Stockholders Rights Plan
02/09/24 PayPal downgraded, United Airlines upgraded: Wall Street's top analyst calls
02/08/24 Synlogic Announces Decision to Discontinue Synpheny-3 Study and Provides Corporate Update
02/02/24 Synlogic Announces Publication of Preclinical and Clinical Data for SYNB1353 as a Potential Treatment for Classical Homocystinuria
01/16/24 Sidoti Events, LLC's Virtual January Micro-Cap Conference
01/04/24 Synlogic Provides Corporate Update and Outlook for 2024
12/27/23 Synlogic Announces Contract with the Air Force Research Lab
12/07/23 Synlogic Announces Abstract Accepted for Poster Presentation at the International Conference on Microbiome Engineering 2023
SYBX Chatroom

User Image insiderbuyingselling Posted - 10/30/24

$SYBX new insider selling: 79 shares. http://insiderbuyingselling.com/?t=SYBX

User Image frontiere Posted - 10/30/24

$SYBX Synlogic ref=$1.46 — no pstn — 👍 the last of 4 (four) busted biotech shells that have hired LUCID CAPITAL MARKERS — a less than 1 yr old IB boutique — to advise them on strategic alternatives. So far 3 finished with fireworks: 👍 $ABIO Arca ➔ $ORKA Oruka up 90% on deal PR 👍 $KTRA Kintara ➔ $HURA TuHura up 68% on deal PR (🚩Kintara Nachtrab involved of SAVA infamy) 👍 $GLYC GlycoMimetics ➔ Crescent up 230% on deal PR. Of these, ABIO was at neg EV (MCap<net cash) while others where valued at +EV and used the pumps to raise into deal closings. Thus, current SYBX valuation at premium to net cash (cash ~$20m at 2Q end less $4m liabs w 12.4m shs outst=$1.30 cash per sh pre 3Q) stops us from betting as I don’t see a compelling r:r 🚩but past history (‘Lindy’!) of the 3 deals is evidence for bulls 👍 $JAGX Jaguar was mentioned as Lucid Capital Markets joined Ladenburg there recently to co-run the ATM but as posted below 👇 we see risks and avoid.

User Image epsguid Posted - 3 months ago

$SYBX reported earnings of $0.16, consensus was ($0.51) via @eWhispers #epsbeat http://eps.sh/d/sybx

User Image Stock_Titan Posted - 3 months ago

$SYBX Synlogic Reports Second Quarter 2024 Financial Results https://www.stocktitan.net/news/SYBX/synlogic-reports-second-quarter-2024-financial-j5ni2htk3398.html

User Image NVDAMillionaire Posted - 3 months ago

$SYBX SYNlogic, Inc.: A Promising Synthetic Biotic Pipeline Targeting Rare Metabolic Diseases http://beyondspx.com/2024/08/01/synlogic-inc-a-promising-synthetic-biotic-pipeline-targeting-rare-metabolic-diseases/

User Image NVDAMillionaire Posted - 4 months ago

$SYBX Synlogic, Inc. (NASDAQ:SYBX): Navigating Challenges Amidst Strategic Shifts http://beyondspx.com/2024/07/10/synlogic-inc-nasdaqsybx-navigating-challenges-amidst-strategic-shifts/

User Image epsguid Posted - 6 months ago

$SYBX reported a loss of $2.60, consensus was ($0.80) via @eWhispers #epsmiss http://eps.sh/d/sybx

User Image Stock_Titan Posted - 6 months ago

$SYBX Synlogic Reports First Quarter 2024 Financial Results https://www.stocktitan.net/news/SYBX/synlogic-reports-first-quarter-2024-financial-4fc6ai01b0j1.html

User Image Fullratio Posted - 7 months ago

Healthcare sector stocks with high revenue growth in Q4 2023 (TTM): $SAGE $KRYS $SYBX

User Image insiderbuyingselling Posted - 7 months ago

$SYBX new insider selling: 372 shares. http://insiderbuyingselling.com/?t=SYBX

User Image Fullratio Posted - 8 months ago

$SYBX gross profit has soared by 186% YoY: https://fullratio.com/stocks/nasdaq-sybx/synlogic

User Image epsguid Posted - 8 months ago

$SYBX reported a loss of $1.71, consensus was ($1.11) via @eWhispers #epsmiss http://eps.sh/d/sybx

User Image DonCorleone77 Posted - 8 months ago

$SYBX Synlogic reports Q4 EPS ($1.71), consensus (97c) Reports Q4 revenue $2.77M, consensus $2.73M.

User Image Stock_Titan Posted - 8 months ago

$SYBX Synlogic Reports Fourth Quarter and Full Year 2023 Financial Results https://www.stocktitan.net/news/SYBX/synlogic-reports-fourth-quarter-and-full-year-2023-financial-t1aozdq3vejm.html

User Image cta7978 Posted - 02/28/24

$DNA Is Synlogic $SYBX going bankrupt? Looks like they abandoned their probiotic treatment with labafenogene marselecobac (SYNB1934) as a potential treatment for phenylketonuria (PKU). Market cap down to $17 Million. Didn't Ginkgo own 20% of the company? I guess they will be able to write it off? https://finance.yahoo.com/news/synlogic-announces-decision-discontinue-synpheny-211500711.html

User Image debbiekatz Posted - 8 months ago

$SYBX at 2.06 may be risky though

User Image VahidinSuljic Posted - 9 months ago

$SYBX it's coming🤑🤑

User Image Stock_Titan Posted - 9 months ago

$SYBX Synlogic Adopts Limited Duration Stockholders Rights Plan https://www.stocktitan.net/news/SYBX/synlogic-adopts-limited-duration-stockholders-rights-7vk9dowepnrn.html

User Image DianeJones849 Posted - 9 months ago

$SYBX & TNXP: Growth collab goals. Dive into their playbook!

User Image ToddSnyder722 Posted - 9 months ago

$SYBX collaboration game is strong. Catch what they're up to! Meanwhile

User Image theflynews Posted - 9 months ago

Biotech Alert: Searches spiking for these stocks today - $SYBX - https://thefly.com/permalinks/entry.php/SYBXid3861521

User Image EternalBull777 Posted - 9 months ago

$DNA what is the impact of $SYBX going out of business to $DNA ? https://www.reddit.com/r/ginkgobioworks/s/vfwpZlaCDz

User Image Game_Day Posted - 9 months ago

Latest alerts 🕰️ Stocks $ILAG ⭐️ 15% $SYBX ⭐️ 10% $SYRA ⭐️ 6% $SUNWQ ⭐️ 11% Options EL ⭐️ 15% PEP ⭐️ 5%

User Image lecorb Posted - 9 months ago

$SYBX $BTAI $ZJYL $SYRA $LTRX Etc.. HOLO HKIT Horror movie!

User Image Stocksrunner Posted - 9 months ago

🔍 Today Top Losers: $SYBX: Synlogic shares plummet after failed drug study and discontinuation of lead program. 📉 $VLCN: Volcon's short interest drops significantly. 📉 $EXPE: Expedia faces challenges with CEO change and softening air fares, leading to a 13% premarket plunge. 📉 Stay vigilant and adapt your strategies accordingly!

User Image _www_larval_com_ Posted - 9 months ago

$SYBX just reverted 8% higher to -47% (~4Mv) a few minutes ago, 02/16 options, follow for more volatility.

User Image Ninja_Tradez Posted - 9 months ago

TOP LOSERS FROM MARKET OPEN $SYBX | Price: 1.8 | $ Change: -1.65 | % Percent: -47.8261% $PLCE | Price: 10.875 | $ Change: -8.875 | % Percent: -44.9367% $BTAI | Price: 2.2505 | $ Change: -1.4995 | % Percent: -39.9867% $ZJYL | Price: 8.01 | $ Change: -4.95 | % Percent: -38.1944% $EMKR | Price: 0.3998 | $ Change: -0.229 | % Percent: -36.4186%

User Image Ninja_Tradez Posted - 9 months ago

TOP LOSERS FROM MARKET OPEN $SYBX | Price: 1.785 | $ Change: -1.665 | % Percent: -48.2609% $ZJYL | Price: 6.94 | $ Change: -6.02 | % Percent: -46.4506% $PLCE | Price: 10.63 | $ Change: -9.12 | % Percent: -46.1772% $BTAI | Price: 2.325 | $ Change: -1.425 | % Percent: -38% $MLGO | Price: 0.6551 | $ Change: -0.3849 | % Percent: -37.0096%

User Image Ninja_Tradez Posted - 9 months ago

TOP LOSERS FROM MARKET OPEN $PLCE | Price: 9.7 | $ Change: -10.05 | % Percent: -50.8861% $ZJYL | Price: 6.74 | $ Change: -6.22 | % Percent: -47.9938% $SYBX | Price: 1.78 | $ Change: -1.67 | % Percent: -48.4058% $BTAI | Price: 2.3277 | $ Change: -1.4223 | % Percent: -37.928% $EMKR | Price: 0.42 | $ Change: -0.2088 | % Percent: -33.2061%

User Image tchnvst Posted - 9 months ago

$DNA surprised the $SYBX closure hasn't impacted this. The deal was likely a blend of cash and stock so i thought this would impact the book value of $DNA immediately...but seems like investors don't care. perhaps the number of bets >> individual portfolio failures.

Analyst Ratings
HC Wainwright & Co. Neutral Mar 20, 24
Chardan Capital Neutral Feb 9, 24
Leerink Partners Market Perform Feb 9, 24
HC Wainwright & Co. Sell Feb 9, 24
Alliance Global Partners Buy Dec 11, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Brennan Aoife See Remarks See Remarks Apr 04 Sell 2.4459 8,894 21,754 275,343 04/06/22
Awad Antoine Chief Operating Offi.. Chief Operating Officer Apr 04 Sell 2.4459 2,650 6,482 81,170 04/06/22